James W. Galbraith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
James W. Galbraith has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
Joel B. Rodgers
8 shared publicationsHenry E. Wang
From the *Division of Pediatric Emergency Medicine, Department of Pediatrics, †Department of Emergency Medicine, ‡Department of Epidemiology, School of Public Health, §Department of Medical Education, University of Alabama School of Medicine, Birmingham, AL
5 shared publications- John P. Donnelly
Department of Learning Health Sciences, University of Michigan Medical School, Ann Arbor, MI
5 shared publications Ricardo A. Franco
5 shared publications- Ricardo A. Franco
Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama
3 shared publications Edgar T. Overton
Department of Medicine,Division of Infectious Diseases,University of Alabama School of Medicine,Birmingham,AL
2 shared publications
Latest Publications
- Open Access
- 13 January 2021
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 48 (8) , 529-535
Prevalence of Chlamydia trachomatis Infection in Young Women and Associated Predictors
Background: Chlamydia trachomatis (CT) infection remains highly prevalent, and young women are disproportionately affected. Most CT-infected women are asymptomatic, and their infection often goes unrecognized and untreated. We hypothesized that testing for active CT infection with molecular diagnostics and obtaining a reported history of CT infection underestimate the prevalence of current and past CT infection, and incorporating serum CT antibody testing in addition to these other prevalence measures would generate more accurate estimates of the prevalence of CT infection in asymptomatic young women. Methods: We enrolled 362 asymptomatic women aged 16 to 29 years at 4 different clinical settings in Birmingham, AL, between August 2016 and January 2020 and determined the prevalence of CT infection based on having 1 or more of the following prevalence measures: an active urogenital CT infection based on molecular testing, reported prior CT infection, and/or being CT seropositive. Multivariable regression analysis was used to determine predictors of the prevalence of CT infection after adjustment for participant characteristics. Results: The prevalence of CT infection was 67.7% (95% confidence interval, 62.6%–72.5%). Addition of CT antibody testing to the other individual prevalence measures more than doubled the CT infection prevalence. Non-Hispanic Black race, reported prior gonorrhea, and reported prior trichomoniasis predicted a higher prevalence of CT infection. Conclusions: More than half of women were unaware of ever having CT infection, suggesting many were at risk for CT-associated reproductive complications. These data reinforce the need to adhere to chlamydia screening guidelines and to increase screening coverage in those at risk.
- 13 January 2021
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 48 (8) , 529-535
Open AccessPrevalence of Chlamydia trachomatis Infection in Young Women and Associated Predictors
Background: Chlamydia trachomatis (CT) infection remains highly prevalent, and young women are disproportionately affected. Most CT-infected women are asymptomatic, and their infection often goes unrecognized and untreated. We hypothesized that testing for active CT infection with molecular diagnostics and obtaining a reported history of CT infection underestimate the prevalence of current and past CT infection, and incorporating serum CT antibody testing in addition to these other prevalence measures would generate more accurate estimates of the prevalence of CT infection in asymptomatic young women. Methods: We enrolled 362 asymptomatic women aged 16 to 29 years at 4 different clinical settings in Birmingham, AL, between August 2016 and January 2020 and determined the prevalence of CT infection based on having 1 or more of the following prevalence measures: an active urogenital CT infection based on molecular testing, reported prior CT infection, and/or being CT seropositive. Multivariable regression analysis was used to determine predictors of the prevalence of CT infection after adjustment for participant characteristics. Results: The prevalence of CT infection was 67.7% (95% confidence interval, 62.6%–72.5%). Addition of CT antibody testing to the other individual prevalence measures more than doubled the CT infection prevalence. Non-Hispanic Black race, reported prior gonorrhea, and reported prior trichomoniasis predicted a higher prevalence of CT infection. Conclusions: More than half of women were unaware of ever having CT infection, suggesting many were at risk for CT-associated reproductive complications. These data reinforce the need to adhere to chlamydia screening guidelines and to increase screening coverage in those at risk.
- 1 January 2021
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 60 (1) , e13-e17
Emergency Medicine Interest Groups
- 1 January 2021
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 60 (1) , e13-e17
Emergency Medicine Interest Groups
- 1 July 2020
- Published by Elsevier in The American Journal of Surgery
- Vol. 220 (1) , 83-89
Sleep and stress before and after duty across residency years under 2017 ACGME hours
- 1 July 2020
- Published by Elsevier in The American Journal of Surgery
- Vol. 220 (1) , 83-89
Sleep and stress before and after duty across residency years under 2017 ACGME hours
- 15 May 2020
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 69 (19) , 569-574
High Prevalence of Hepatitis C Infection Among Adult Patients at Four Urban Emergency Departments — Birmingham, Oakland, Baltimore, and Boston, 2015–2017
This report describes a new study that found universal hepatitis C testing in emergency departments identified a greater number of previously unrecognized infections, especially in persons born after 1965.
- 15 May 2020
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 69 (19) , 569-574
High Prevalence of Hepatitis C Infection Among Adult Patients at Four Urban Emergency Departments — Birmingham, Oakland, Baltimore, and Boston, 2015–2017
This report describes a new study that found universal hepatitis C testing in emergency departments identified a greater number of previously unrecognized infections, especially in persons born after 1965.
- Open Access
- 24 February 2020
- Published by Western Journal of Emergency Medicine in Western Journal of Emergency Medicine
- Vol. 21 (2) , 203-208
Human Papillomavirus Awareness, Vaccine Status, and Risk Factors in Female Emergency Patients
Introduction: A vaccine targeting high-risk human papillomavirus (HPV) strains can effectively prevent HPV-associated cervical cancer risk. However, many girls and women do not receive the vaccine, more often those impacted by health disparities associated with race and/or socioeconomic status. This same disparate population has also been shown to be at higher risk for cervical cancer. Many of these women also rely on the emergency department (ED) as a safety net for their healthcare. This study sought to gather information pertaining to HPV and cervical cancer risk factors, awareness of HPV and the vaccine, as well as HPV vaccine uptake in female patients presenting to an ED.Methods: We obtained 81 surveys completed by female ED patients. Demographics included age, race, income, insurance status, primary care provider status, and known cervical-cancer risk factors. Subsequent survey questions explored respondents’ knowledge, familiarity, and attitudes regarding HPV, cervical cancer, and the HPV vaccine, including vaccination uptake rates. We analyzed data using descriptive statistics and Fisher’s exact test.Results: Approximately one in seven respondents (14.8%) had never previously heard of HPV and 32.1% were unaware of the existence of a HPV vaccine. Minority patients, including those who were Black and Hispanic patients, low income patients, and uninsured and publicly insured patients were less likely to be aware of HPV and the vaccine and likewise were less likely to be offered and receive the vaccine. More than 60% of all respondents (61.3%) had never previously been offered the vaccine, and only 24.7% of all respondents had completed the vaccine series.Conclusion: Female ED patients may represent an at-risk cohort with relatively low HPV awareness and low HPV vaccine uptake. The ED could represent a novel opportunity to access and engage high-risk HPV populations.
- 24 February 2020
- Published by Western Journal of Emergency Medicine in Western Journal of Emergency Medicine
- Vol. 21 (2) , 203-208
Open AccessHuman Papillomavirus Awareness, Vaccine Status, and Risk Factors in Female Emergency Patients
Introduction: A vaccine targeting high-risk human papillomavirus (HPV) strains can effectively prevent HPV-associated cervical cancer risk. However, many girls and women do not receive the vaccine, more often those impacted by health disparities associated with race and/or socioeconomic status. This same disparate population has also been shown to be at higher risk for cervical cancer. Many of these women also rely on the emergency department (ED) as a safety net for their healthcare. This study sought to gather information pertaining to HPV and cervical cancer risk factors, awareness of HPV and the vaccine, as well as HPV vaccine uptake in female patients presenting to an ED.Methods: We obtained 81 surveys completed by female ED patients. Demographics included age, race, income, insurance status, primary care provider status, and known cervical-cancer risk factors. Subsequent survey questions explored respondents’ knowledge, familiarity, and attitudes regarding HPV, cervical cancer, and the HPV vaccine, including vaccination uptake rates. We analyzed data using descriptive statistics and Fisher’s exact test.Results: Approximately one in seven respondents (14.8%) had never previously heard of HPV and 32.1% were unaware of the existence of a HPV vaccine. Minority patients, including those who were Black and Hispanic patients, low income patients, and uninsured and publicly insured patients were less likely to be aware of HPV and the vaccine and likewise were less likely to be offered and receive the vaccine. More than 60% of all respondents (61.3%) had never previously been offered the vaccine, and only 24.7% of all respondents had completed the vaccine series.Conclusion: Female ED patients may represent an at-risk cohort with relatively low HPV awareness and low HPV vaccine uptake. The ED could represent a novel opportunity to access and engage high-risk HPV populations.
- 1 December 2019
- Published by Elsevier in International Journal of Drug Policy
- Vol. 74, 229-235
Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama
- 1 December 2019
- Published by Elsevier in International Journal of Drug Policy
- Vol. 74, 229-235
Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama
- 29 November 2019
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 38 (7) , 1396-1401
Predictors of linkage to care for a nontargeted emergency department hepatitis C screening program
- 29 November 2019
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 38 (7) , 1396-1401
Predictors of linkage to care for a nontargeted emergency department hepatitis C screening program
- 1 August 2019
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 57 (2) , 290-291
Author Response to Letter to the Editor Regarding “Potential Problems of Using Same Race Category for Native Hawaiians, Pacific Islanders, and Asians”
- 1 August 2019
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 57 (2) , 290-291
Author Response to Letter to the Editor Regarding “Potential Problems of Using Same Race Category for Native Hawaiians, Pacific Islanders, and Asians”
- Open Access
- 1 November 2018
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 55 (5) , S40-S48
Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes
- 1 November 2018
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 55 (5) , S40-S48
Open AccessRacial and Geographic Disparities in Hepatocellular Carcinoma Outcomes
- 1 November 2018
- Published by Elsevier in Addictive Behaviors
- Vol. 86, 51-55
Medical, psychosocial, and treatment predictors of opioid overdose among high risk opioid users
- 1 November 2018
- Published by Elsevier in Addictive Behaviors
- Vol. 86, 51-55
Medical, psychosocial, and treatment predictors of opioid overdose among high risk opioid users